{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:41:30Z","timestamp":1784734890185,"version":"3.55.0"},"reference-count":24,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"DOI":"10.1182\/bloodadvances.2023009806","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T16:43:55Z","timestamp":1684773835000},"page":"4035-4038","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["<i>Pseudomonas aeruginosa<\/i> ExoU-associated virulence in HCT recipients and patients with hematologic malignancies"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6931-2198","authenticated-orcid":false,"given":"Lauren","family":"Fontana","sequence":"first","affiliation":[{"name":"1Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Strasfeld","sequence":"additional","affiliation":[{"name":"2Division of Infectious Diseases, Oregon Health and Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Hakki","sequence":"additional","affiliation":[{"name":"2Division of Infectious Diseases, Oregon Health and Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"issue":"6","key":"2023080716551943200_bib1","first-page":"1068","article-title":"Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance","volume":"70","author":"Martinez-Nadal","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2023080716551943200_bib2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European Bone Marrow Transplantation Group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2023080716551943200_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2017.05.003","article-title":"Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome","volume":"88","author":"Tofas","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"2023080716551943200_bib4","doi-asserted-by":"crossref","first-page":"105847","DOI":"10.1016\/j.ijantimicag.2019.11.004","article-title":"Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study","volume":"55","author":"Babich","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"2023080716551943200_bib5","doi-asserted-by":"crossref","first-page":"e0199531","DOI":"10.1371\/journal.pone.0199531","article-title":"Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance","volume":"13","author":"Garcia-Vidal","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"2023080716551943200_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00277-012-1424-3","article-title":"P.\u00a0aeruginosa bloodstream infections among hematological patients: an old or new question?","volume":"91","author":"Cattaneo","year":"2012","journal-title":"Ann Hematol"},{"issue":"suppl 4","key":"2023080716551943200_bib7","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1093\/cid\/ciaa1522","article-title":"Risk factors and outcomes of antibiotic-resistant Pseudomonas aeruginosa bloodstream infection in adult patients with acute leukemia","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2023080716551943200_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1042\/BCJ20200780","article-title":"A\u00a0pipeline to evaluate inhibitors of the Pseudomonas aeruginosa exotoxin U","volume":"478","author":"Foulkes","year":"2021","journal-title":"Biochem J"},{"issue":"12","key":"2023080716551943200_bib9","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/emboj\/cdg290","article-title":"The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU","volume":"22","author":"Sato","year":"2003","journal-title":"EMBO J"},{"issue":"12","key":"2023080716551943200_bib10","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/IAI.72.12.6969-6977.2004","article-title":"Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung","volume":"72","author":"Shaver","year":"2004","journal-title":"Infect Immun"},{"issue":"11","key":"2023080716551943200_bib11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/379372","article-title":"Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia","volume":"188","author":"Schulert","year":"2003","journal-title":"J\u00a0Infect Dis"},{"issue":"Pt 10","key":"2023080716551943200_bib12","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1099\/00221287-147-10-2659","article-title":"Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa","volume":"147","author":"Feltman","year":"2001","journal-title":"Microbiology (Reading)"},{"issue":"3","key":"2023080716551943200_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2958.1997.4891851.x","article-title":"ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury","volume":"25","author":"Finck-Barban\u00e7on","year":"1997","journal-title":"Mol Microbiol"},{"issue":"7","key":"2023080716551943200_bib14","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/IAI.68.7.3998-4004.2000","article-title":"Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread","volume":"68","author":"Allewelt","year":"2000","journal-title":"Infect Immun"},{"issue":"4","key":"2023080716551943200_bib15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2958.1998.00727.x","article-title":"PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence","volume":"27","author":"Hauser","year":"1998","journal-title":"Mol Microbiol"},{"issue":"4","key":"2023080716551943200_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/cid\/ciu866","article-title":"Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections","volume":"60","author":"Pe\u00f1a","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2023080716551943200_bib17","doi-asserted-by":"crossref","first-page":"e01759-19-19","DOI":"10.1128\/AAC.01759-19","article-title":"Predictors of mortality in bloodstream infections caused by Pseudomonas aeruginosa and impact of antimicrobial resistance and bacterial virulence","volume":"64","author":"Recio","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2023080716551943200_bib18","doi-asserted-by":"crossref","first-page":"e0253259","DOI":"10.1371\/journal.pone.0253259","article-title":"High pyocyanin production and non-motility of Pseudomonas aeruginosa isolates are correlated with septic shock or death in bacteremic patients","volume":"16","author":"Gupte","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"2023080716551943200_bib19","doi-asserted-by":"crossref","first-page":"106450","DOI":"10.1016\/j.ijantimicag.2021.106450","article-title":"Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia","volume":"58","author":"Recio","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"2023080716551943200_bib20","doi-asserted-by":"crossref","first-page":"dlab125","DOI":"10.1093\/jacamr\/dlab125","article-title":"Emergence of non-susceptibility during persistent","volume":"3","author":"Fontana","year":"2021","journal-title":"JAC Antimicrob Resist"},{"issue":"3","key":"2023080716551943200_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2023080716551943200_bib22","doi-asserted-by":"crossref","first-page":"904602","DOI":"10.3389\/fcimb.2022.904602","article-title":"Long-term dominance of Carbapenem-non-susceptible pseudomonas aeruginosa ST111 in hematologic malignancy patients and hematopoietic cell transplant recipients","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"24","key":"2023080716551943200_bib23","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1042\/BCJ20220527","article-title":"Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity","volume":"479","author":"Foulkes","year":"2022","journal-title":"Biochem J"},{"key":"2023080716551943200_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/fmb-2021-0158","article-title":"Pathogenic arsenal of Pseudomonas aeruginosa: an update on virulence factors","volume":"17","author":"Veetilvalappil","year":"2022","journal-title":"Future Microbiol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/4035\/2069583\/blooda_adv-2023-009806-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/4035\/2069583\/blooda_adv-2023-009806-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T16:55:44Z","timestamp":1691427344000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/15\/4035\/495949\/Pseudomonas-aeruginosa-ExoU-associated-virulence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":24,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,8,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023009806","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}